Does ETESEVIMAB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with ETESEVIMAB. This represents 0.4% of all adverse event reports for ETESEVIMAB.
5
Reports of Malignant neoplasm progression with ETESEVIMAB
0.4%
of all ETESEVIMAB reports
5
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ETESEVIMAB?
Of the 5 reports, 5 (100.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETESEVIMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ETESEVIMAB Cause?
Infusion related reaction (290)
Dyspnoea (214)
Flushing (142)
Covid-19 (122)
Chest discomfort (117)
Nausea (88)
Back pain (85)
Covid-19 pneumonia (80)
Dizziness (74)
Chest pain (67)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ETESEVIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
ETESEVIMAB vs ETHACRYNIC ACID
ETESEVIMAB vs ETHAMBUTOL
ETESEVIMAB vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
ETESEVIMAB vs ETHANOL
ETESEVIMAB vs ETHINYL ESTRADIOL